Bio-Rad InteliQ Tumor Marker Control
- Registration number
- DE0506892
- Model name
- InteliQ Tumor Marker Control Level 1; InteliQ Tumor Marker Control Level 2; InteliQ Tumor Marker Control Level 3; InteliQ Tumor Marker Control Trilevel MiniPak
- Model identifier
- 12008289; 12008290; 12008291; 12008292
- Registration date
- May 26, 2022
- Source update date
- March 21, 2024
- Risk class
- Class C
- Product owner
- Bio-Rad Laboratories Inc.
- Registrant / registration holder
- BIO-RAD LABORATORIES (SINGAPORE) PTE LTD
InteliQ Tumor Marker Control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in the package insert. (AFP, Beta-2- Microglobulin, CA 125, CA15-3, CA 19-9, CA 27.29, CA 72-4, CEA, Cyfra 21-1, Ferritin, hCG, HE4 (Human Epididymis Protein 4, HER-2/neu, IFG- 1/Somatomedin C, ProGRP (Progastrin-Releasing Peptide), Prolactin, Prostatic Acid Phosphatase (PAP), PSA (Free), PSA (Total), Squamous Cell Carcinoma(SCC) and Thyroglobulin).
- Product owner address
- 9500 Jeronimo Road, Irvine, CA 92618, United States
- Registrant address
- 3A INTERNATIONAL BUSINESS PARK, #11-10/16, ICON@IBP, Singapore 609935
This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.